The Hearts in Rhythm Organization: A Canadian National Cardiogenetics Network.


Journal

CJC open
ISSN: 2589-790X
Titre abrégé: CJC Open
Pays: United States
ID NLM: 101763635

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 16 04 2020
accepted: 23 05 2020
entrez: 11 12 2020
pubmed: 12 12 2020
medline: 12 12 2020
Statut: epublish

Résumé

The Hearts in Rhythm Organization (HiRO) is a team of Canadian inherited heart rhythm and cardiomyopathy experts, genetic counsellors, nurses, researchers, patients, and families dedicated to the detection of inherited arrhythmias and cardiomyopathies, provision of best therapies, and protection from the tragedy of sudden cardiac arrest. Recently, existing disease-specific registries were merged into the expanded National HiRO Registry, creating a single common data set for patients and families with inherited conditions that put them at risk for sudden death in Canada. Eligible patients are invited to participate in the registry and optional biobank from 20 specialized cardiogenetics clinics across Canada. Currently, there are 4700 participants enrolled in the National HiRO Registry, with an average of 593 participants enrolled annually over the past 5 years. The capacity to enable knowledge translation of research findings is built into HiRO's organizational infrastructure, with 3 additional working groups (HiRO Clinical Care Committee, HiRO Active Communities Committee, and HiRO Annual Symposium Committee), supporting the organization's current goals and priorities as set alongside patient partners. The National HiRO Registry aims to be an integrated research platform to which researchers can pose novel research questions leading to a better understanding, detection, and clinical care of those living with inherited heart rhythm and cardiomyopathy conditions and ultimately to prevent sudden cardiac death. La Récemment, les registres existants relatifs à des maladies spécifiques ont été fusionnés en un registre national élargi de l’HiRO, créant ainsi un ensemble de données commun unique à destination des patients et leurs familles, atteints de maladies héréditaires, qui sont à risque de mort subite au Canada. Les patients admissibles sont invités à s’associer au registre et à la biobanque facultative regroupant 20 cliniques spécialisées en cardiogénétique au Canada. Actuellement, 4 700 participants sont inscrits au registre national de l’HiRO, avec une moyenne de 593 participants inscrits chaque année au cours des cinq dernières années. La capacité à favoriser l’application des connaissances issues de la recherche fait partie de la structure organisationnelle de l’HiRO, avec trois groupes de travail supplémentaires (comité des soins cliniques de l’HiRO, comité des communautés cctives de l’HiRO et comité du symposium annuel de l’HiRO), soutenant les objectifs et les priorités actuels de l’organisation tels qu’ils ont été fixés en partenariat avec les patients. Le registre national de l’HiRO vise à devenir une plateforme de recherche intégrée au sein de laquelle les chercheurs peuvent exposer des questions de recherche inédites permettant de mieux comprendre, détecter et soigner les personnes atteintes de troubles du rythme cardiaque et de cardiomyopathie héréditaires et, à terme, de prévenir la mort subite d’origine cardiaque.

Sections du résumé

BACKGROUND BACKGROUND
The Hearts in Rhythm Organization (HiRO) is a team of Canadian inherited heart rhythm and cardiomyopathy experts, genetic counsellors, nurses, researchers, patients, and families dedicated to the detection of inherited arrhythmias and cardiomyopathies, provision of best therapies, and protection from the tragedy of sudden cardiac arrest.
METHODS METHODS
Recently, existing disease-specific registries were merged into the expanded National HiRO Registry, creating a single common data set for patients and families with inherited conditions that put them at risk for sudden death in Canada. Eligible patients are invited to participate in the registry and optional biobank from 20 specialized cardiogenetics clinics across Canada.
RESULTS RESULTS
Currently, there are 4700 participants enrolled in the National HiRO Registry, with an average of 593 participants enrolled annually over the past 5 years. The capacity to enable knowledge translation of research findings is built into HiRO's organizational infrastructure, with 3 additional working groups (HiRO Clinical Care Committee, HiRO Active Communities Committee, and HiRO Annual Symposium Committee), supporting the organization's current goals and priorities as set alongside patient partners.
CONCLUSION CONCLUSIONS
The National HiRO Registry aims to be an integrated research platform to which researchers can pose novel research questions leading to a better understanding, detection, and clinical care of those living with inherited heart rhythm and cardiomyopathy conditions and ultimately to prevent sudden cardiac death.
CONTEXTE BACKGROUND
La
MÉTHODES UNASSIGNED
Récemment, les registres existants relatifs à des maladies spécifiques ont été fusionnés en un registre national élargi de l’HiRO, créant ainsi un ensemble de données commun unique à destination des patients et leurs familles, atteints de maladies héréditaires, qui sont à risque de mort subite au Canada. Les patients admissibles sont invités à s’associer au registre et à la biobanque facultative regroupant 20 cliniques spécialisées en cardiogénétique au Canada.
RÉSULTATS UNASSIGNED
Actuellement, 4 700 participants sont inscrits au registre national de l’HiRO, avec une moyenne de 593 participants inscrits chaque année au cours des cinq dernières années. La capacité à favoriser l’application des connaissances issues de la recherche fait partie de la structure organisationnelle de l’HiRO, avec trois groupes de travail supplémentaires (comité des soins cliniques de l’HiRO, comité des communautés cctives de l’HiRO et comité du symposium annuel de l’HiRO), soutenant les objectifs et les priorités actuels de l’organisation tels qu’ils ont été fixés en partenariat avec les patients.
CONCLUSION CONCLUSIONS
Le registre national de l’HiRO vise à devenir une plateforme de recherche intégrée au sein de laquelle les chercheurs peuvent exposer des questions de recherche inédites permettant de mieux comprendre, détecter et soigner les personnes atteintes de troubles du rythme cardiaque et de cardiomyopathie héréditaires et, à terme, de prévenir la mort subite d’origine cardiaque.

Autres résumés

Type: Publisher (fre)
La

Identifiants

pubmed: 33305225
doi: 10.1016/j.cjco.2020.05.006
pii: S2589-790X(20)30065-2
pmc: PMC7710951
doi:

Types de publication

Journal Article

Langues

eng

Pagination

652-662

Informations de copyright

© 2020 Canadian Cardiovascular Society. Published by Elsevier Inc.

Références

Eur Heart J. 2017 Sep 1;38(33):2565-2568
pubmed: 26245334
Can J Cardiol. 2016 Dec;32(12):1396-1401
pubmed: 27474350
Circ Cardiovasc Genet. 2017 Jun;10(3):
pubmed: 28600387
Open Heart. 2020 Jan 20;7(1):e001195
pubmed: 32076566
Circ Arrhythm Electrophysiol. 2012 Oct;5(5):933-40
pubmed: 22944906
Circulation. 2010 Nov 30;122(22):2335-48
pubmed: 21147730
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Circ Arrhythm Electrophysiol. 2016 Sep;9(9):
pubmed: 27635072
Europace. 2019 Nov 1;21(11):1725-1732
pubmed: 31408100
Eur Heart J. 2014 Oct 14;35(39):2733-79
pubmed: 25173338
Circulation. 2020 Feb 11;141(6):429-439
pubmed: 31941373
Circulation. 2009 Jul 28;120(4):278-85
pubmed: 19597050
Eur Heart J. 2013 Sep;34(33):2636-48, 2648a-2648d
pubmed: 23824828
Circulation. 2010 Apr 6;121(13):1533-41
pubmed: 20172911
J Am Coll Cardiol. 2013 Jul 16;62(3):222-230
pubmed: 23563135
Circ Arrhythm Electrophysiol. 2016 Apr;9(4):e004012
pubmed: 27069091
Heart Rhythm. 2013 Dec;10(12):1932-63
pubmed: 24011539
Circ Arrhythm Electrophysiol. 2017 Aug;10(8):
pubmed: 28794082
Int J Cardiol. 2004 Dec;97(3):499-501
pubmed: 15561339
J Am Coll Cardiol. 2009 Apr 28;53(17):1475-87
pubmed: 19389557
Can J Cardiol. 2017 Jun;33(6):814-821
pubmed: 28347582
Heart Rhythm. 2013 Apr;10(4):517-23
pubmed: 23232084
Acta Cardiol Sin. 2018 May;34(3):267-277
pubmed: 29844648
Heart Rhythm. 2014 Jun;11(6):1047-54
pubmed: 24657429
Circulation. 2009 Nov 3;120(18):1761-7
pubmed: 19841298
Circulation. 1995 Aug 15;92(4):785-9
pubmed: 7641357
JACC Clin Electrophysiol. 2017 Mar;3(3):276-288
pubmed: 29759522

Auteurs

Brianna Davies (B)

Division of Cardiology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Jason D Roberts (JD)

Section of Cardiac Electrophysiology, Division of Cardiology, Department of Medicine, Western University, London, Ontario, Canada.

Rafik Tadros (R)

Cardiovascular Genetics Center, Montreal Heart Institute, Montreal, Québec, Canada.
Department of Medicine, Université de Montréal, Montreal, Québec, Canada.

Martin S Green (MS)

Heart Institute, University of Ottawa, Ottawa, Ontario, Canada.

Jeffrey S Healey (JS)

Population Health Research Institute, Hamilton, Ontario, Canada.

Christopher S Simpson (CS)

Department of Medicine, Queen's University, Kingston, Ontario, Canada.

Shubhayan Sanatani (S)

Children's Heart Centre, BC Children's Hospital, Vancouver, British Columbia, Canada.

Christian Steinberg (C)

Institut Universitaire de Cardiologie et Pneumologie de Québec, Laval University, Québec City, Québec, Canada.

Ciorsti MacIntyre (C)

Division of Cardiology, QEII Health Sciences Center, Halifax, Nova Scotia, Canada.

Paul Angaran (P)

St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.

Henry Duff (H)

Libin Cardiovascular Institute, University of Calgary, Calgary, Alberta, Canada.

Robert Hamilton (R)

Division of Cardiology, The Hospital for Sick Children (SickKids), Toronto, Ontario, Canada.

Laura Arbour (L)

Division of Medical Genetics, Island Health, Victoria, British Columbia, Canada.

Richard Leather (R)

Royal Jubilee Hospital, Victoria, British Columbia, Canada.

Colette Seifer (C)

Section of Cardiology, Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.

Anne Fournier (A)

Division of Pediatric Cardiology, CHU Sainte-Justine, Université de Montréal, Montreal, Québec, Canada.

Joseph Atallah (J)

Division of Pediatric Cardiology, University of Alberta Stollery Children's Hospital, Edmonton, Alberta, Canada.

Shane Kimber (S)

Division of Cardiology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.

Bhavanesh Makanjee (B)

Heart Health Institute, Scarborough Health Network, Scarborough, Ontario, Canada.

Wael Alqarawi (W)

Heart Institute, University of Ottawa, Ottawa, Ontario, Canada.

Julia Cadrin-Tourigny (J)

Cardiovascular Genetics Center, Montreal Heart Institute, Montreal, Québec, Canada.
Department of Medicine, Université de Montréal, Montreal, Québec, Canada.

Jacqueline Joza (J)

Division of Cardiology, McGill University Health Centre, Montreal, Québec, Canada.

Jimmy McKinney (J)

Division of Cardiology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Stephanie Clarke (S)

Shared Health Genetics & Metabolism Program, University of Manitoba, Winnipeg, Manitoba, Canada.

Zachary W M Laksman (ZWM)

Division of Cardiology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Karen Gibbs (K)

Division of Cardiology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Vuk Vuksanovic (V)

Q-Statistic, Toronto, Ontario, Canada.

Martin Gardner (M)

Division of Cardiology, QEII Health Sciences Center, Halifax, Nova Scotia, Canada.

Mario Talajic (M)

Cardiovascular Genetics Center, Montreal Heart Institute, Montreal, Québec, Canada.
Department of Medicine, Université de Montréal, Montreal, Québec, Canada.

Andrew D Krahn (AD)

Division of Cardiology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Classifications MeSH